Home Your basket
• Positioning in the oropha...
   Price 8.50 €
• Post-operative complicati...
   Price 10.50 €
• Utility of positron emiss...
   Price 8.50 €
• Melanotic neuroectodermal...
   Price 8.50 €
• Saddle nose surgery: Long...
   Price 10.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 10.50 €
• Partial allotransplantati...
   Price 10.50 €
• Difficult blepharoplastie...
   Price 10.50 €
• Nasal tumours of the thre...
   Price 10.50 €
• Augmentation of the abdom...
   Price 10.50 €
• Validation of a self-asse...
   Price 10.50 €
• Zenker's diverticulum: Te...
   Price 10.50 €
• Surgical procedure in fir...
   Price 8.50 €
• Eustachian tube melanoma ...
   Price 8.50 €
• Diagnosis management of W...
   Price 10.50 €
• Multidisciplinary managem...
   Price 14.00 €
• Surgery of the semicircul...
   Price 12.50 €
• Idiopathic sudden deafnes...
   Price 10.50 €
• The Bell Labs contributio...
   Price 12.50 €
• Iatrogenic scarring of th...
   Price 12.00 €
• Voice Handicap Index adap...
   Price 10.50 €
• Management of cervical ce...
   Price 10.50 €
• Rhinophyma in a black afr...
   Price 5.50 €
• The eye movement autophon...
   Price 14.00 €
• Paediatric airway endosco...
   Price 5.50 €
• Navigation in head and ne...
   Price 10.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Cemento-ossifying fibroma...
   Price 8.50 €
• Changing patterns of bucc...
   Price 10.50 €
• Static management of lago...
   Price 10.50 €
• Nystagmus and vibratory t...
   Price 10.50 €
• Hearing evaluation on you...
   Price 8.50 €
• A study of peristomal rec...
   Price 5.50 €
• The expanding domain of i...
   Price 10.50 €
• Evaluation of the presenc...
   Price 12.50 €

Total Order 351.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE